| Document |
Document Title |
|
WO/2019/169141A1 |
The invention provides a method of producing and using extracellular vesicles (ECVs) derived from activated stromal cells for the treatment of certain disease and conditions. Specifically, ECVs derived from preactivated mesenchymal cells...
|
|
WO/2019/162613A1 |
The invention relates to a new composition comprising a solution of at least one acrylic adhesive and particles of a crosslinked polymer having a carboxylate group density of 2.0 to 12.0 meq/g and an average pore size of 0.005 to 1.0 μm...
|
|
WO/2019/162123A1 |
The invention relates to a method for producing superabsorbent particles, comprising the steps of drying a polymer, separating incompletely dried polymer particles, comminuting the separated polymer particles, recirculating the comminute...
|
|
WO/2019/162216A1 |
The invention relates to a method for measuring characteristic values of superabsorbers, wherein an excess aqueous solution or dispersion is presented, the superabsorber is allowed to swell in the presented aqueous solution or dispersion...
|
|
WO/2019/162735A1 |
A flatulence odor eliminating sanitary pad has at least one odor filtering inner layer disposed between a first fabric outer layer and a second fabric outer layer of a pad body. The at least one odor filtering inner layer is made of a ch...
|
|
WO/2019/161131A1 |
A bandage device having a flexible body with a plurality of fluid reservoirs thereon each containing a liquid topical treatment therein. Mixing areas located between the respective fluid reservoirs on the bandage provide for mixing and f...
|
|
WO/2019/158926A1 |
The present invention relates to a haemostatic material which is effective at controlling the flow of blood from both standard and coagulopathic wound injuries, whilst maintaining a reduced compression time, minimising the requirement fo...
|
|
WO/2019/156648A1 |
The invention relates to adhesion barriers used in the biomedical field. The invention relates in particular to a nanofibrous mat suitable for use as an adhesion barrier in the biomedical field and obtained by the electrospinning method ...
|
|
WO/2019/154652A1 |
The invention relates to a method for the pneumatic delivery of superabsorbent particles, the superabsorbent particles being mixed with an aqueous wax dispersion prior to the pneumatic delivery, the wax having a glass transition temperat...
|
|
WO/2019/156583A1 |
The invention relates to the field of medicine and cosmetology. A method is proposed for producing an agent for the treatment of wounds in the form of a gel based on water-soluble polysaccharides of plant origin, said method consisting i...
|
|
WO/2019/155406A1 |
The present invention relates to a device for displacing a volume of liquid. The device is formed mainly by a water-retaining polymer (20) contained in a receptacle (10) having a flexible wall that is semipermeable to water. The device i...
|
|
WO/2019/152695A1 |
The present invention includes compositions and methods of making films, adhesive patches, or composites comprising a polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (PCL-PVAc-PEG) and a partially hydrophilic ...
|
|
WO/2019/152522A1 |
The present invention is directed to a method of producing extracellular vesicles compositions from conditioned culture medium (CCM) compositions. The method includes culturing cells under hypoxic conditions on a biocompatible surface in...
|
|
WO/2019/152640A1 |
The present disclosure describes a wound dressing that incorporates a biopolymer scaffold, such as a keratin-based scaffold, into collagen-based materials to increase the mechanical strength of the wound dressing. The biopolymers can inc...
|
|
WO/2019/152110A1 |
An antimicrobial composition may comprise a surfactant. The antimicrobial composition may include about 30 μg/ml to about 1,000 μg/ml of the surfactant, by volume of the antimicrobial composition. The surfactant may comprise a docusate...
|
|
WO/2019/144221A1 |
Compositions for treating bedsores and methods for treating bedsores are provided. The compositions include a therapeutically effective amount of nabilone and may be formulated for oral or topical administration. The composition may furt...
|
|
WO/2019/147262A1 |
A wetness indicating composition can include a mixing solvent including water and a water-miscible volatile organic solvent. The wetness indicating composition can also include an amphiphilic polydiacetylene and a hydrophobic binder. In ...
|
|
WO/2019/145892A1 |
A wetness indicator composition comprising at least one pH-indicator colorant, from about 0.001% to about 75% by weight of at least one color-stabilizer, and from 0.1% to 70% by weight of at least one hardening agent, and wherein the wet...
|
|
WO/2019/146726A1 |
Provided is a long-fiber non-woven fabric that: is suitable for a top-sheet or back-sheet part of an absorbent article that is to be used in a sanitary material; achieves both high strength and a bulkiness that provides a cushioning soft...
|
|
WO/2019/145383A1 |
The present invention relates to the use of a combination of a wound-rinsing solution and cold atmospheric plasma for treating wounds. The present invention further relates to a method for treating wounds, comprising rinsing the wound wi...
|
|
WO/2019/146656A1 |
A spun-bonded nonwoven fabric that comprises a fiber formed of a composition, said composition containing a propylene homopolymer having a melting point of 140°C or higher, a polyethylene and at least one kind of polymer selected from t...
|
|
WO/2019/140572A1 |
A wound dressing and a manufacturing method thereof. The wound dressing comprises two or more of a gel fiber, a textile fiber, and a thermoplastic fiber. The gel fiber content is 50-100%. The textile fiber content is 0-50%. The thermopla...
|
|
WO/2019/144162A1 |
An orthopedic splint system comprising self-curing splinting system that is applied to an injured limb without use of water. The splint material is contained in tear resistant outer pouch and an inner protective sleeve where a water-lade...
|
|
WO/2019/137879A1 |
The invention relates to a method for producing polyurethane foams, wherein compositions comprising A) isocyanate-functional prepolymers which can be obtained by reacting A1) aliphatic, low-molecular diisocyanates with a molar mass of 14...
|
|
WO/2019/137882A1 |
The invention relates to a method for producing polyurethane foams, wherein compositions comprising A) isocyanate-functional prepolymers which can be obtained by reacting A1) low-molecular diisocyanates with a molar mass of 140 to 278 g/...
|
|
WO/2019/137833A1 |
Disclosed are superabsorber mixtures M containing at least 70 wt% of superabsorber A, which has a 20 g/g liquid uptake (T20) of less than 300 s and/or volumetric absorption under load (VAUL) below 0.3 psi (2.07 kPa) with a τ value of le...
|
|
WO/2019/137414A1 |
A product for treating a bleeding wound in a human or animal body comprises a biocompatible hemostatic composition and a biocompatible tissue sealant. The product may be used to control bleeding from external wounds and internal injuries...
|
|
WO/2019/134982A1 |
The present disclosure relates to birch bark extracts, methods of producing such extracts, stable pharmaceutical compositions containing such extracts and methods of using of such extracts. The birch bark extracts of the present disclosu...
|
|
WO/2019/133899A1 |
The present invention relates to a biocompatible, foldable, thin profile, low mass and high surface area, chitosan dressing, optionally modified with catechol, and suitable for treating bleeding in a physiological environment, e.g. bladd...
|
|
WO/2019/133898A1 |
The present invention relates to a biocompatible, foldable, thin profile, low mass and high surface area, chitosan dressing, optionally modified with catechol, and suitable for treating bleeding in a physiological environment, e.g. gastr...
|
|
WO/2019/133931A1 |
The present disclosure relates to a gastrointestinal delivery device of a chitosan dressing, where the delivery device is capable of stop bleeding, in particular in connection with TURP procedures. The delivery device may be used in all ...
|
|
WO/2019/133936A1 |
The present invention relates to a biocompatible, foldable, thin profile, low mass and high surface area, chitosan dressing, optionally modified with catechol, and suitable for treating bleeding in a physiological environment, e.g., gast...
|
|
WO/2019/133823A1 |
The invention is directed to extracellular matrix replacement (EMR)-drug conjugates or EMR-fluorescent label conjugates, to methods of making the EMR-drug conjugates or EMR-fluorescent label conjugates, to pharmaceutical compositions com...
|
|
WO/2019/133894A1 |
The present disclosure relates to a gastrointestinal delivery device of a dressing, where the delivery device is capable of fitting through a narrow channel before expanding and applying the dressing. The gastrointestinal delivery device...
|
|
WO/2019/128372A1 |
Disclosed is a gauze pad (100), the embodiments thereof relating to the field of medical technology. The gauze pad (100) comprises: a moisture sustaining layer (30), the moisture sustaining layer (30) being provided in the gauze pad (100...
|
|
WO/2019/124408A1 |
This meltblown non-woven fabric has an average fiber diameter of 4 μm or lower. In a first direction that is in the plane of the meltblown non-woven fabric and has the highest percentage of straight-running fibers and in a second direct...
|
|
WO/2019/119097A1 |
The present invention describes a method for obtaining a polymeric blend of Caesalpinia pulcherrima galactomannan and coconut water powder (ACP). In addition, the present invention describes the polymeric blend obtained by means of the m...
|
|
WO/2019/125962A1 |
In some aspects, the present invention provides an active dressing for transfer of superficial epidermal biopsies to a wound site, where the dressing can enhance keratinocyte out growth from the biopsies at the wound site and improve the...
|
|
WO/2019/119019A1 |
A haemostat agent in the form of a multi-layer patch comprising at least first and second layers, wherein said first layer comprises a composition comprising fibrous β-chitin (which may be sourced from a marine source such as squid pens...
|
|
WO/2019/126368A1 |
A dressing for wound healing is provided herein including dehydrated placental tissue, collagen, and oxidized regenerated cellulose. The dehydrated placental tissue may be present in a first layer and the collagen and the oxidized regene...
|
|
WO/2019/123360A1 |
A method is provided for preparing a film of crosslinked microfibrillated cellulose. Phosphorylated microfibrillated cellulose is cast or wet-laid into a film; and then said film is post-treated (e.g. by heat-treatment) to provide crossl...
|
|
WO/2019/121376A1 |
The present invention relates to wound dressings, more particularly for the need-based treatment of chronic and/or infected wounds, comprising a Bronsted acid and a pH-sensitive polymer, wherein the Bronsted acid is embedded in a matrix ...
|
|
WO/2019/125043A1 |
A hydrocolloid composition and a biopatch comprising the same are provided. The hydrocolloid composition comprises a hydrophobic elastic polymer matrix. Hydrocolloid particles and aerogel particles are dispersed within the matrix. The ae...
|
|
WO/2019/123389A1 |
The present disclosure provides a foam nasal dressing for topically administering an active agent to a nasal cavity and for absorbing fluid discharge. The foam nasal dressing comprises a foamed core portion and a foamed shell portion arr...
|
|
WO/2019/123444A1 |
The invention provides a wound dressing made by an ex vivo formed combination of fibrinogen and/or fibrin containing-liquid formulation and an oxidized cellulose (OC) backing; and use thereof.
|
|
WO/2019/123358A1 |
A method is provided for preparing a fibrous material (preferably a mat or filaments) of crosslinked microfibrillated cellulose. Phosphorylated microfibrillated cellulose is spun into a fibrous material; and then said fibrous material is...
|
|
WO/2019/115645A1 |
The present invention generally relates to a medical dressing for prevention of pressure ulcers. The dressing comprises a gel pad having a low compressive strength; i.e. from 5 kPa to 60 kPa at a strain of 50%, as measured by the compres...
|
|
WO/2019/116126A1 |
The aim of the invention is to obtain a highly porous biodegradable absorbent material, produced from fruit exocarp and mesocarp and mycelia of macromycetic fungi. The material is structured in two layers, one of which is waterproof. The...
|
|
WO/2019/115643A1 |
The present invention generally relates to a medical dressing for prevention of pressure ulcers. The dressing comprises a gel pad and an anisotropic layer being stiffer in one layer direction. The dressing reduces the shear and compressi...
|
|
WO/2019/113641A1 |
An incontinence assist appliance for a user comprises an envelope including a surface, such as an upper outside surface, for contact with the user. A removable bladder is receivable within the envelope and includes a port for attachment ...
|
